Glutathione

Glutathione (GSH) is the body’s main antioxidant inside your cells — a small peptide (a short chain of amino acids) that your cells build on their own. It has more real human research behind it than most “biohacking” compounds, but that research is mixed, and most of the studies are small and short. The one result that holds up well is that taking glutathione by mouth can raise the amount your body has on hand. The things it’s actually sold for — IV drips for skin lightening, anti-aging, “detox,” recovery, and performance — haven’t been proven in people, and the injectable beauty market is where the documented harm shows up. This profile separates the real chemistry from the marketing.

What it is

Glutathione is a peptide your body makes naturally (gamma-L-glutamyl-L-cysteinyl-glycine), built in nearly every human cell in two energy-using steps. The supply of one ingredient, the amino acid cysteine, is usually what caps how much your body can make — so N-acetylcysteine (NAC), which feeds the body cysteine, is actually the better-proven way to push glutathione levels up.

It’s a true peptide (just three amino acids), not a hormone, a SARM (a muscle-targeting drug), or a steroid. Here’s what it’s known to do:

• It’s your cells’ main antioxidant and “redox” balancer (redox = the constant give-and-take of electrons that keeps cell chemistry in balance). A reactive sulfur group (the -SH, or thiol) on its cysteine grabs and neutralizes harmful reactive oxygen and nitrogen molecules.
• It’s a working part for two important enzyme jobs. It’s the raw material for glutathione peroxidases (enzymes that break down peroxides) and glutathione-S-transferases (enzymes that tag toxins and other reactive compounds so the body can clear them — this is part of “phase II” detoxification, the body’s chemical clean-up system). It also recharges vitamins C and E and keeps proteins working by way of the GSH/GSSG balance (the back-and-forth between glutathione’s “charged” and “spent” forms).
• It affects skin pigment. In pigment cells (melanocytes), glutathione blocks tyrosinase (the enzyme that kicks off pigment production) and nudges pigment toward lighter pheomelanin instead of darker eumelanin. That’s the chemistry behind the cosmetic “skin-lightening” pitch — but a believable mechanism isn’t the same thing as a proven result in real people.

The claims

Online and in clinics, glutathione is sold for skin lightening / “glow” (by far the biggest real-world use, usually as IV drips or injections), anti-aging, “detox” and liver support, immune support, and athletic recovery and performance. Most of these — especially the anti-aging, detox, recovery, and performance claims — are stretched from glutathione’s known chemistry and from lab-dish and animal studies, not from solid trials measuring real outcomes in people.

What the evidence actually shows

• Does it survive being swallowed? — the long-running question. People long assumed glutathione was mostly broken down in the gut. The best human trial (Richie et al., 2015, n=54, 6 months, double-blind and placebo-controlled — meaning neither patients nor researchers knew who got the real thing) showed that oral glutathione (250 or 1,000 mg/day) did raise the body’s glutathione stores — about 30–35% in red blood cells, plasma, and lymphocytes (a type of immune cell), and roughly 260% in cheek-lining cells at the higher dose — with the effect mostly fading after a one-month break. But another trial (Allen & Bradley, 2011, 4 weeks**)** found no meaningful change in markers of oxidative stress or in glutathione status. So it probably works orally, but the results aren’t consistent; newer liposomal/micellar formulas (versions wrapped in tiny fat bubbles to help absorption) are still early and only tested in small studies.
• Parkinson’s disease — the most-studied serious use, and a telling one. An early open-label IV study (Sechi 1996, n=9, meaning everyone knew they were getting the drug) reported about 42% improvement in disability, but studies without a comparison group can only suggest ideas, not prove them. A randomized, double-blind, placebo-controlled IV pilot (Hauser 2009, n=21) was well tolerated but showed no real difference from placebo on the standard Parkinson’s rating scale (UPDRS). Delivering it through the nose does measurably reach the brain (Mischley 2016, about a 269% rise in brain glutathione measured by MRI scan) — so getting it to the brain works — but the strongest test, a randomized placebo-controlled Phase IIb nasal trial (Mischley 2017, NCT02424708, n=45), came up negative: neither dose beat placebo (and the placebo group improved a lot on its own). The best Parkinson’s evidence is a “no effect” result.
• Fatty liver (NAFLD). An open-label, single-arm, multicenter pilot (Honda 2017, 34 enrolled / 29 finished, 4 months of oral glutathione) lowered ALT (a liver enzyme that flags liver stress) and triglycerides (a blood fat). Encouraging, but with no comparison group it needs a proper randomized trial.
• Skin lightening — the shakiest evidence compared to how hard it’s sold. A 2025 narrative review (Cureus) found no published clinical trials of injectable glutathione for skin lightening and no agreed-on dosing guidelines, and flagged side effects (including liver problems and a case of anaphylaxis, a severe whole-body allergic reaction) in the groups studied. The few oral and topical studies are small, short, and low-quality. The claimed benefits aren’t established, and whatever benefit there is seems to fade once you stop.
• General antioxidant / longevity / recovery / performance. Mostly stretched from lab-dish and animal work and from glutathione’s chemistry — not from solid human outcome trials. Treat this marketing as thin and unproven in people.

Bottom line so far: there’s solid human evidence that “oral glutathione can raise your body’s glutathione stores,” and it was reasonably well tolerated in the trials. But raising a lab number isn’t the same as proving a real health or cosmetic benefit, and the most rigorous disease trial (Parkinson’s) found nothing.

Legal and regulatory status

• FDA (US): Glutathione is not an FDA-approved drug for any wellness, cosmetic, or anti-aging use. Oral and topical versions are sold as dietary supplements or cosmetic ingredients; the injectable/IV glutathione used in clinics is compounded (mixed to order by a pharmacy), not an FDA-approved finished product. The FDA has flatly warned compounders not to use the dietary-supplement form of glutathione to make injectables, citing concerns about quality and endotoxins (bacterial contaminants that can trigger dangerous reactions). The 2019 action focused on L-glutathione powder labeled “Caution: Dietary Supplement” (distributed by Letco Medical; FDA testing found bacterial endotoxin up to about 5x the appropriate limit), with seven documented patient reactions ranging from nausea and vomiting to trouble breathing, one of which required hospitalization. There is no FDA-approved injectable glutathione for skin lightening.
• International: The Philippine FDA — a major market for IV “skin-whitening drips” — issued Advisory No. 2019-182 warning against unsafe use of glutathione as a skin-lightener, citing no clinical trials, no dosing guidelines, and risks including liver, kidney, and nervous-system toxicity, Stevens-Johnson syndrome (a serious skin reaction), and infections passed along through injections. (In the Philippines, injectable glutathione is approved only as an add-on during cisplatin chemotherapy — not for cosmetic use.)
• Controlled-substance status: Glutathione is not a DEA-scheduled controlled substance.
• Anti-doping (WADA): Glutathione itself is not on the 2026 WADA Prohibited List — it isn’t a banned substance in any category. The real anti-doping catch is the delivery method and amount: IV infusions or injections of more than 100 mL per 12-hour period are banned under WADA Section M2, “Chemical and Physical Manipulation” (specifically item M2.2) — unless it’s legitimate hospital treatment, surgery, a clinical diagnostic test, or done with a TUE (a Therapeutic Use Exemption, official permission to use an otherwise-restricted treatment). So a large-volume “glutathione drip” can break the rules because of the infusion method and volume, no matter what’s in the bag — the same rule applies even to allowed fluids like saline or vitamins. (A related category, M1, covers “Manipulation of Blood and Blood Components”; the IV-volume rule lives under M2, not M1.)

Safety

• Oral glutathione: Generally well tolerated in trials at the doses studied over weeks to months, with no serious safety red flags in the trials above. Long-term safety data are limited.
• Intranasal (through-the-nose) glutathione: Tolerated in the Parkinson’s trials.
• IV/injectable glutathione — the riskiest use, and where the documented harm is:
  • Endotoxin reactions (nausea and vomiting that can progress to trouble breathing and hospitalization) from poorly controlled compounded product — the basis of the FDA action and a published case series (seven patients, one hospitalized).
  • Severe allergic reactions — a case of anaphylaxis was documented in the groups studied.
  • Risks flagged by regulators from high-dose cosmetic drips, including Stevens-Johnson syndrome and possible liver, kidney, and nervous-system effects.
  • Infections passed along through non-sterile injections. Sterility, dosing, and product quality aren’t regulated in this setting.

The molecule itself is low-toxicity and something your body already makes. The danger is the unregulated injectable/IV cosmetic market — contamination, allergic reactions, no quality control — not glutathione itself. The FDA and dermatology experts agree the evidence doesn’t support IV glutathione for skin whitening.

Bottom line

Glutathione is a real antioxidant peptide your body makes, with more human data than most biohacking compounds — but that data is mixed and mostly small and short. The reliable finding is that oral glutathione can raise your body’s glutathione stores; that’s real, but it isn’t proof of the anti-aging, detox, recovery, performance, or skin-lightening benefits it’s sold for. The most rigorous disease trial (nasal glutathione for Parkinson’s) found nothing, and the skin-lightening evidence is weak, short-lived, and dominated by an injectable market that regulators have warned about. The peptide is low-toxicity; the IV cosmetic drip is the risky part.

Evidence grade: 6/10 · Preliminary.

Sources

• Richie JP, et al. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. Eur J Nutr. 2015;54(2):251-263. PMID 24791752
• Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers. J Altern Complement Med. 2011;17(9). PMID 21875351
• Hauser RA, et al. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson’s disease. Mov Disord. 2009;24(7). PMID 19230029
• Sechi G, et al. Reduced intravenous glutathione in the treatment of early Parkinson’s disease. Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(7):1159-1170
• Mischley LK, et al. Central nervous system uptake of intranasal glutathione in Parkinson’s disease. NPJ Parkinsons Dis. 2016;2:16002. PMC5516583
• Mischley LK, et al. Phase IIb study of intranasal glutathione in Parkinson’s disease. J Parkinsons Dis. 2017. NCT02424708. PMC5438472
• Honda Y, et al. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterol. 2017;17(1):96. PMC5549431
• Alzahrani TF, et al. Exploring the Safety and Efficacy of Glutathione Supplementation for Skin Lightening: A Narrative Review. Cureus. 2025. PMC11862975
• FDA highlights concerns with using dietary ingredient glutathione to compound sterile injectables
• FDA warns compounders not to use glutathione from Letco Medical to compound sterile drugs
• Philippine FDA Advisory No. 2019-182, Unsafe Use of Glutathione as a Skin-Lightening Agent
• WADA publishes 2026 Prohibited List (glutathione not listed; IV infusion >100 mL/12 h restricted under M2 Chemical and Physical Manipulation, M2.2)
• USADA: Athlete Advisory — What’s New on the 2026 WADA Prohibited List?